When Ursinus College offered a choice between on-campus classes or teaching and learning from home this semester, every faculty member and student was empowered to take the path that was right for them.

Two neuroscientists write that a new understanding of the neuropilin-1 protein could speed vaccine research

Most accounts to date have focused on how the virus invades cells via the ACE2 protein on the surface of many cells. But recent studies suggest there is another route that enables it to infect the nervous system.

Through the end of September, 79% of COVID-19 deaths in the U.S. were in patients over 65. Monocytes from older individuals produce less interferon in response to viral infections.

With data collection slowed and grant applications way up, the pandemic is disrupting the complex, slow-moving NIH funding system. Federal officials and university grant administrators are working to help researchers keep things moving.

As the world awaits vaccines to bring the COVID-19 pandemic under control, UC San Francisco scientists have devised a novel approach to halting the spread of SARS-CoV-2, the virus that causes the disease.

Scientists in Germany tested the malaria drugs on various cell types and found they can block coronavirus infection in kidney cells from the African green monkey but don’t inhibit the virus in human lung cells.

In a summer dominated by COVID-19 and protests against racial injustice, there are growing demands that drugmakers and investigators ensure that vaccine trials reflect the entire community.

Our bodies have two main types of T cells. Together they can help us fend off this virus

They’re easier to manufacture than traditional vaccines, but scientifically their history is checkered

Amid a wavering federal response that has allowed staggering levels of disease to sweep the country, the All of Us program is a potential bright spot.